These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21470243)

  • 1. Relative lack of T regulatory cells in adult eosinophilic esophagitis - no normalization after corticosteroid therapy.
    Stuck MC; Straumann A; Simon HU
    Allergy; 2011 May; 66(5):705-7. PubMed ID: 21470243
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased number of regulatory T cells in children with eosinophilic esophagitis.
    Fuentebella J; Patel A; Nguyen T; Sanjanwala B; Berquist W; Kerner JA; Bass D; Cox K; Hurwitz M; Huang J; Nguyen C; Quiros JA; Nadeau K
    J Pediatr Gastroenterol Nutr; 2010 Sep; 51(3):283-9. PubMed ID: 20639775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic esophagitis: treatment with oral viscous budesonide.
    Zur E
    Int J Pharm Compd; 2012; 16(4):288-93. PubMed ID: 23050387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid treatment of eosinophilic esophagitis in adults.
    Alexander JA
    Gastroenterol Clin North Am; 2014 Jun; 43(2):357-73. PubMed ID: 24813521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction.
    Aceves SS; Chen D; Newbury RO; Dohil R; Bastian JF; Broide DH
    J Allergy Clin Immunol; 2010 Dec; 126(6):1198-204.e4. PubMed ID: 21047675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroids in pediatric eosinophilic esophagitis.
    Contreras EM; Gupta SK
    Gastroenterol Clin North Am; 2014 Jun; 43(2):345-56. PubMed ID: 24813520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on topical steroid therapy for eosinophilic esophagitis.
    Molina-Infante J; Lucendo AJ
    Gastroenterol Hepatol; 2015; 38(6):388-97. PubMed ID: 25630928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic esophagitis.
    Nurko S
    J Pediatr Gastroenterol Nutr; 2011 Dec; 53 Suppl 2():S13-5. PubMed ID: 22235452
    [No Abstract]   [Full Text] [Related]  

  • 9. Eosinophilic esophagitis: it is here to stay.
    Alexander JA; Katzka DA
    Clin Gastroenterol Hepatol; 2011 May; 9(5):370-2. PubMed ID: 21277391
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidental gastric eosinophils in patients with eosinophilic esophagitis: do they matter?
    Ammoury RF; Rosenman MB; Roettcher D; Gupta SK
    J Pediatr Gastroenterol Nutr; 2010 Dec; 51(6):723-6. PubMed ID: 20601904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials.
    Edwards SJ; von Maltzahn R; Naya IP; Harrison T
    Int J Clin Pract; 2010 Apr; 64(5):619-27. PubMed ID: 20456215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The proportion of regulatory T cells in the peripheral blood reflects the relapse or remission status of patients with Churg-Strauss syndrome.
    Saito H; Tsurikisawa N; Tsuburai T; Oshikata C; Akiyama K
    Int Arch Allergy Immunol; 2011; 155 Suppl 1():46-52. PubMed ID: 21646795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new treatment for eosinophilic esophagitis: oral viscous budenoside].
    Lancho Monreal EM; Fernández Fernández S; Echeverria Zudaire L; Cilleruelo Pascual ML; Rodrigo García G
    An Pediatr (Barc); 2011 May; 74(5):341-3. PubMed ID: 21376686
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dysphagia in the younger patient: the eosinophilic esophagitis].
    Criblez DH
    Rev Med Suisse; 2011 Jan; 7(279):240-1. PubMed ID: 21387731
    [No Abstract]   [Full Text] [Related]  

  • 15. Addressing the Challenges of Off-label Corticosteroid Use in Eosinophilic Esophagitis.
    Patel RH; Parikh C; Singh MP; Sharma RK; Gaidhane S; Anand A
    J Clin Gastroenterol; 2024 Aug; 58(7):738. PubMed ID: 38896429
    [No Abstract]   [Full Text] [Related]  

  • 16. In eosinophilic esophagitis, budesonide orodispersible tablets maintained remission at 48 wk.
    Srinivasan S; Sharma P
    Ann Intern Med; 2021 Apr; 174(4):JC44. PubMed ID: 33819066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with oral PUVA and corticosteroid for recalcitrant alopecia areata.
    Ito T; Aoshima M; Ito N; Uchiyama I; Sakamoto K; Kawamura T; Yagi H; Hashizume H; Takigawa M
    Arch Dermatol Res; 2009 Jun; 301(5):373-80. PubMed ID: 19301021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the consistency more important than the ingredients for steroid treatment in eosinophilic esophagitis?
    Parrish DW; Sharma S; Kumar S
    Ann Allergy Asthma Immunol; 2014 Apr; 112(4):286-9. PubMed ID: 24566294
    [No Abstract]   [Full Text] [Related]  

  • 19. CD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids.
    Azab NA; Bassyouni IH; Emad Y; Abd El-Wahab GA; Hamdy G; Mashahit MA
    Clin Immunol; 2008 May; 127(2):151-7. PubMed ID: 18299252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.